Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoChange DetectedThe web page has updated its date references, adding new dates in April 2025 while removing older dates from March 2025.SummaryDifference0.2%
- Check23 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed study protocols and inclusion criteria for a clinical trial on enfortumab vedotin, while adding new identifiers and collaborators related to the study.SummaryDifference53%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 13, 2025.SummaryDifference0.1%
- Check37 days agoChange DetectedThe page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3.SummaryDifference0.1%
- Check52 days agoChange DetectedThe webpage has updated its date references, removing older dates from February 2025 and adding new dates in March 2025.SummaryDifference0.2%
Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.